Salt la conținut
Global sound
ASX BRIEFS

ASX BRIEFS

CYCLOPHARM LTD (ASX:CYC) - Why Lung Imaging Guidelines Are Shifting Towards Technegas

· 13 min

Note de episod

Send us Fan Mail ASX Investment Opportunity - Cyclopharm Ltd (ASX:CYC) China’s leading medical bodies have now named Technegas the preferred ventilation agent for pulmonary embolism imaging, and that single line has big implications. We sit down with Cyclopharm Managing Director and CEO James McBrayer to unpack what’s driving the sudden global alignment of clinical guidelines across the US, Europe, Australia and New Zealand, and China and why it’s rare for medical guidance to call out a bran...

Live, ultima oră: 5.016 melodii pe 1.923 posturi din 108 țări

Descoperă lumea prin radio

Mai multe moduri de a descoperi (7)

Ai auzit ceva frumos? Salvează-l sau deschide-l direct în Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
Victoria JusticeContinuă să asculți